The search for disease-modifying treatment for Alzheimer's disease

被引:80
|
作者
Aisen, PS
Davis, KL
机构
关键词
D O I
10.1212/WNL.48.5_Suppl_6.35S
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
As a result of advances in the understanding of neurodegenerative mechanisms in Alzheimer's disease, several strategies for the development of disease-modifying treatment are being investigated. Nerve growth factor and other neurotrophins may improve neuronal survival, although targeted delivery remains an obstacle. Modulation of protein processing has the potential to decrease the formation of plaques and tangles. Pharmacologic reduction of oxidative stress and destructive inflammation may slow the rate of neurodegeneration. Continued research into basic mechanisms, along with therapeutic trials of promising drugs, are improving the likelihood that it will soon be possible to slow the progression of this disease.
引用
收藏
页码:S35 / S41
页数:7
相关论文
共 50 条
  • [41] Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease
    Gustavsson, Anders
    Pemberton-Ross, Peter
    Montero, Melissa Gomez
    Hashim, Mahmoud
    Thompson, Robin
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (06) : 563 - 570
  • [42] Overview of potential targets for disease-modifying drugs in Alzheimer's disease
    Cuello, A. Claudio
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 4 - 4
  • [43] Current issues in the development of disease-modifying drugs for Alzheimer's disease
    Okamura, Nobuyuki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S56 - S56
  • [44] Neuroinflammation in Alzheimer's disease:: Potential targets for, disease-modifying drugs
    Hüll, M
    Hampel, H
    [J]. NEUROINFLAMMATION - FROM BENCH TO BEDSIDE, 2002, 39 : 159 - 178
  • [45] The past, present, and future of disease-modifying therapies for Alzheimer's disease
    Suzuki, Kazushi
    Iwata, Atsushi
    Iwatsubo, Takeshi
    [J]. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2017, 93 (10): : 757 - 771
  • [46] Alzheimer's disease: From molecular pathology to disease-modifying therapy
    Iwatsubo, Takeshi
    [J]. NEUROSCIENCE RESEARCH, 2011, 71 : E4 - E4
  • [47] In search for a disease-modifying treatment in irritable bowel syndrome
    Tornblom, Hans
    Simren, Magnus
    [J]. GUT, 2016, 65 (01) : 2 - 3
  • [48] EFFECT OF MORTALITY ON COST-EFFECTIVENESS MODELING OF DISEASE-MODIFYING TREATMENT FOR ALZHEIMER'S DISEASE
    Aye, S.
    Jonsson, L.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S483 - S483
  • [49] Aluminum in the Diet and Alzheimer's Disease: From Current Epidemiology to Possible Disease-Modifying Treatment
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Capurso, Cristiano
    Kehoe, Patrick G.
    Imbimbo, Bruno P.
    Santamato, Andrea
    Dellegrazie, Flora
    Seripa, Davide
    Pilotto, Alberto
    Capurso, Antonio
    Panza, Francesco
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (01) : 17 - 30
  • [50] Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease
    Aye, Sandar
    Jonsson, Linus
    Gustavsson, Anders
    Tate, Ashley
    Ptacek, Sara Garcia
    Eriksdotter, Maria
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (01)